Enhancing Scale-Up, Increasing Quality, and Reducing Costs for AVs, LVVs, AAVs and More The 3rd Viral Vector Process Development and Manufacturing Summit returns to Boston, uniting industry leaders ...

The use of viral vectors as gene delivery and vaccine vehicles has developed rapidly during the last two decades owing to several viral properties. Viruses can infect cells efficiently, often have a ...

Genezen has opened its new process development and analytical lab for viral vector production. Genezen, a cell and gene therapy contract development and manufacturing organization, has officially ...

Effective process development for viral vector-based medicines is paramount for optimized process efficiency, robustness, scalability, and product quality. Well-designed processes streamline ...

Green vector for exceptionally sustainable solutions, also awarding 1,000 euros.

The timely Viral Vector Formulation and Process Development Summit Europe is the only definitive, end-to-end platform, uniting 60+ experts across up-and downstream process development, formulation, ...

Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...

Data truly isn’t just about numbers or spreadsheets anymore. With artificial intelligence (AI) and machine learning (ML) at the forefront of innovation, data is taking on new forms and uses, ...

2 in-depth workshops to give you hands-on experience within 6 hrs 2 tracks dedicated to process development and manufacturing, bridging the gaps of PD and CMC and Tech Transfer Exclusive Data-Driven ...